Despite the lack of a clear unique signature for IBC, a greater propensity for gene clustering, which is consistent with more aggressive basal-like or ErbB2 molecular subtypes, has been reported, with less frequent IBC tumors demonstrating luminal A subtype gene clustering [23]. The gene discussed is ERBB2; the disease is inflammatory breast carcinoma.